Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Favier, FR
Alain Favier, Nogent-Sur-Marne FR
| Patent application number | Description | Published |
|---|---|---|
| 20120011904 | ANTITHEFT DEVICE FOR MERCHANDISE INCLUDING MEANS FOR THE PLACEMENT AND SIMPLIFIED REMOVAL THEREOF - An antitheft device ( | 01-19-2012 |
Alain Favier, Bernin FR
| Patent application number | Description | Published |
|---|---|---|
| 20110027807 | PROTEIN SPECIFIC TO PANCREATIC BETA CELLS IN ISLETS OF LANGERHANS AND APPLICATIONS THEREOF - The invention relates to protein ZnT-8 which is specifically expressed in the pancreatic beta cells in islets of Langerhans, to a polynucleotide encoding said protein which is involved in the maturation and exocytosis of insulin, and to the applications thereof, for example, for sorting and studying beta cells and for screening medicine acting on diabetes and hyperinsulinism. | 02-03-2011 |
Anne-Laure Favier, Latronche Cedex FR
| Patent application number | Description | Published |
|---|---|---|
| 20110171256 | VIRAL STRAINS DERIVED FROM THE VACCINIA VIRUS LISTER VACV-107 AND USES THEREOF - The present invention relates to viral strains derived from the vaccinia virus Lister VACV-107 and to pharmaceutical composition containing the viral strains. More particularly, the present invention relates to a viral strain derived from the vaccinia virus Lister VACV-107 wherein strain contains in its genomic sequence (SEQ ID N°1) at least one deletion selected from the group consisting of: deletion of the nucleotides 19758 to 28309 in the sequence ID NO°1 (Δ18), deletion of the nucleotides 161293 to 164811 in the sequence ID NO°1 (Δ20), deletion of the nucleotides 181231 to 183304 in the sequence ID NO°1 (Δ21), deletion of the nucleotides 6118 to 9677 in the sequence ID NO°1 (Δ22), deletion of the nucleotides 1833 to 3574 and 185848 to 187589 in the sequence ID NO°1 (Δ23). | 07-14-2011 |
Benoit Favier, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20110268737 | HLA-G PROTEINS AND PHARMACEUTICAL USES THEREOF - The present invention relates to novel proteins and pharmaceutical uses thereof. The invention more specifically relates to novel fusion proteins comprising a domain of an HLA-G antigen fused to an Fc domain of an immunoglobulin. The invention also relates to methods of producing such polypeptides, pharmaceutical compositions comprising the same, as well as their uses for treating various diseases including organ/tissue rejection. | 11-03-2011 |
| 20110274711 | HLA-G POLYPEPTIDES AND PHARMACEUTICAL USES THEREOF - The present invention relates to novel proteins and pharmaceutical uses thereof The invention more specifically relates to novel proteins comprising the sequence of an HLA-5 antigen fused to the sequence of a b2 microglobulin. The invention also relates to methods of producing such polypeptides, pharmaceutical compositions comprising the same, as well as their uses for treating various diseases including organ/tissue rejection. | 11-10-2011 |
Boris Favier, Lyon FR
| Patent application number | Description | Published |
|---|---|---|
| 20110028554 | PHARMACEUTICAL COMPOSITIONS COMPRISING DIIODOTHYRONINE AND THEIR THERAPEUTIC USE - The present invention relates to a pharmaceutical composition comprising, as active substance, at least one hormone chosen among 3,5-diiodothyronine (3,5-T2), 3′,3-diiodothyronine (3′,3-T2), 3′,5-diiodothyronine (3′,5-T2), 3′-iodothyronine (3′-T), 3-iodothyronine (3-T) or 5-iodothyronine (5-T), in association with a pharmaceutically acceptable vehicle. | 02-03-2011 |
| 20110064773 | PHARMACEUTICAL COMPOSITIONS COMPRISING A THYROID HORMON AND THEIR THERAPEUTIC USE - The present invention relates to a pharmaceutical composition comprising, as active substance, at least one hormone chosen among 3′,5′,3-triiodothyronine (rT3), a rT3 derived hormone, or a precursor of rT3, such as T4 in association with a molecule susceptible to promote the formation of rT3, in association with a pharmaceutically acceptable vehicle. | 03-17-2011 |
Franck Favier, Lyon FR
| Patent application number | Description | Published |
|---|---|---|
| 20110028554 | PHARMACEUTICAL COMPOSITIONS COMPRISING DIIODOTHYRONINE AND THEIR THERAPEUTIC USE - The present invention relates to a pharmaceutical composition comprising, as active substance, at least one hormone chosen among 3,5-diiodothyronine (3,5-T2), 3′,3-diiodothyronine (3′,3-T2), 3′,5-diiodothyronine (3′,5-T2), 3′-iodothyronine (3′-T), 3-iodothyronine (3-T) or 5-iodothyronine (5-T), in association with a pharmaceutically acceptable vehicle. | 02-03-2011 |
Georges Favier, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20080196872 | Compact Water/Water Heat Pump Core, and Heat Pump Comprising Same - The whole set includes a compressor assembly ( | 08-21-2008 |
| 20090025902 | Probe For Collecting Thermal Energy From The Ground For A Heat Pump, And A Collection Network Equipped With Such Probes - The probe ( | 01-29-2009 |
| 20100293982 | HEATING AND AIR-CONDITIONING INSTALLATION WITH A HEAT PUMP, THE INSTALLATION INCLUDING AT LEAST ONE HEAT TRANSFER FLUID DISTRIBUTOR UNIT WITH COUPLING TO A PLURALITY OF HEAT COLLECTION AND DELIVERY CIRCUITS - The distributor unit ( | 11-25-2010 |
Jean-Jacques Favier, Montastruc La Conseillere FR
| Patent application number | Description | Published |
|---|---|---|
| 20110187860 | COMPRESSION OF EARTH OBSERVATION SATELLITE IMAGES - A method of acquiring, compressing and transmitting satellite images, characterized in that in a systematic manner: an image is acquired ( | 08-04-2011 |
| 20110206096 | METHOD AND SYSTEM FOR ACQUIRING AND REPATRIATING SATELLITE DATA - A method of acquiring and repatriating satellite data representative of a zone in space, termed the target zone, and an instrument for acquiring and repatriating satellite data including a plurality of satellites ( | 08-25-2011 |
Michelle Favier, Jonage FR
| Patent application number | Description | Published |
|---|---|---|
| 20110028554 | PHARMACEUTICAL COMPOSITIONS COMPRISING DIIODOTHYRONINE AND THEIR THERAPEUTIC USE - The present invention relates to a pharmaceutical composition comprising, as active substance, at least one hormone chosen among 3,5-diiodothyronine (3,5-T2), 3′,3-diiodothyronine (3′,3-T2), 3′,5-diiodothyronine (3′,5-T2), 3′-iodothyronine (3′-T), 3-iodothyronine (3-T) or 5-iodothyronine (5-T), in association with a pharmaceutically acceptable vehicle. | 02-03-2011 |
| 20110064773 | PHARMACEUTICAL COMPOSITIONS COMPRISING A THYROID HORMON AND THEIR THERAPEUTIC USE - The present invention relates to a pharmaceutical composition comprising, as active substance, at least one hormone chosen among 3′,5′,3-triiodothyronine (rT3), a rT3 derived hormone, or a precursor of rT3, such as T4 in association with a molecule susceptible to promote the formation of rT3, in association with a pharmaceutically acceptable vehicle. | 03-17-2011 |
Roland Favier, Jonage FR
| Patent application number | Description | Published |
|---|---|---|
| 20110028554 | PHARMACEUTICAL COMPOSITIONS COMPRISING DIIODOTHYRONINE AND THEIR THERAPEUTIC USE - The present invention relates to a pharmaceutical composition comprising, as active substance, at least one hormone chosen among 3,5-diiodothyronine (3,5-T2), 3′,3-diiodothyronine (3′,3-T2), 3′,5-diiodothyronine (3′,5-T2), 3′-iodothyronine (3′-T), 3-iodothyronine (3-T) or 5-iodothyronine (5-T), in association with a pharmaceutically acceptable vehicle. | 02-03-2011 |
| 20110064773 | PHARMACEUTICAL COMPOSITIONS COMPRISING A THYROID HORMON AND THEIR THERAPEUTIC USE - The present invention relates to a pharmaceutical composition comprising, as active substance, at least one hormone chosen among 3′,5′,3-triiodothyronine (rT3), a rT3 derived hormone, or a precursor of rT3, such as T4 in association with a molecule susceptible to promote the formation of rT3, in association with a pharmaceutically acceptable vehicle. | 03-17-2011 |
Yann Favier, Jonage FR
| Patent application number | Description | Published |
|---|---|---|
| 20110028554 | PHARMACEUTICAL COMPOSITIONS COMPRISING DIIODOTHYRONINE AND THEIR THERAPEUTIC USE - The present invention relates to a pharmaceutical composition comprising, as active substance, at least one hormone chosen among 3,5-diiodothyronine (3,5-T2), 3′,3-diiodothyronine (3′,3-T2), 3′,5-diiodothyronine (3′,5-T2), 3′-iodothyronine (3′-T), 3-iodothyronine (3-T) or 5-iodothyronine (5-T), in association with a pharmaceutically acceptable vehicle. | 02-03-2011 |
| 20110064773 | PHARMACEUTICAL COMPOSITIONS COMPRISING A THYROID HORMON AND THEIR THERAPEUTIC USE - The present invention relates to a pharmaceutical composition comprising, as active substance, at least one hormone chosen among 3′,5′,3-triiodothyronine (rT3), a rT3 derived hormone, or a precursor of rT3, such as T4 in association with a molecule susceptible to promote the formation of rT3, in association with a pharmaceutically acceptable vehicle. | 03-17-2011 |